Theranos Fraud Exposure and Collapse
Market Context & Analysis
Starting Price: $9000.00Wall Street Journal exposes Theranos blood-testing technology as fraudulent. Elizabeth Holmes claimed revolutionary testing from finger prick. Reality: used conventional machines and faked results. $9B valuation evaporates. Criminal charges follow. Becomes cautionary tale about Silicon Valley hype.
Strong economy. Biotech and healthcare innovation highly valued. Unicorn startups proliferating. Venture capital abundant.
Healthcare innovation encouraged. FDA oversight of diagnostics relatively loose initially. Then Theranos triggers regulatory crackdown.
Theranos had Walgreens partnership, famous board members. Elizabeth Holmes on magazine covers. Then WSJ investigation reveals fraud—technology never worked. Company dissolves, Holmes charged criminally.
Silicon Valley hype at peak. Fake it till you make it culture. Investors not doing diligence. Board of politicians and generals, no scientists. Reality check coming.
- Technology never actually worked—complete fraud
- Elizabeth Holmes lied to investors, partners, patients
- Used conventional machines and faked results
- Famous investors and board members fooled
- Patient safety endangered by false results
- Criminal charges for fraud
- $9B valuation to zero